USPTO 2015–2025 USPTO PatentsView US Corporation

Alcon Lensx, Inc.

USPTO PatentsView assignee record - 25 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Alcon ranks #11,905 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 5 technology areas.

#11,905
of 49,997 US assignees by volume
34th percentile
by Innovation Score (30.3/100)
18.6
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11905 · US Corporation #11,905 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #11,905/49,997
  • PHOTO-FINISH Aalyria
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 30.3/100
  • CLAIMS-RICH 18.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aalyria Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alcon’s 30.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Alcon

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Alcon's Innovation Score is 30.3/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Alcon?

Each dot is one of Alcon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alcon’s own 18.6 claims/patent is ABOVE the 18.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alcon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 1416182022 Granted patents (volume) Avg claims / patent Aalyria Technologies, Inc. - 25, 18.8AalyriaAdisseo France S.A.S. - 25, 15.2Adisseo France SAgena Bioscience, Inc. - 25, 20.48Agena BioscienceAirspan Networks Inc. - 25, 20.6Airspan NetworksAlere SAN Diego, Inc. - 25, 19.68Alere SAN DiegoAlexza Pharmaceuticals, Inc. - 25, 15.08Alexza Pharmaceut…Alza Corporation - 25, 17.08AlzaApator Miitors APS - 25, 18.12Apator Miitors APSAlcon Lensx, Inc. - 25, 18.6Alcon Lensx
Alcon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alcon's grants concentrate

Alcon Lensx, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (10 grants) versus a trough of 2 in 2019. By volume, Alcon sits between Aalyria Technologies, Inc. and Apator Miitors APS.

Who files at Alcon's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Alcon holds 25 patents at rank #11,896, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Alcon

By rank, the assignees closest to #11,896 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Alcon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alcon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Alcon ranks #260 of 3,082 assignees by patent count in that subclass.

Alcon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 2015201620172019 2
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Alcon Lensx, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 32.0%
2016 10 40.0%
2017 5 20.0%
2019 2 8.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Alcon Lensx, Inc.'s patent record in context - here's where to go next.

  • Alcon Lensx, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #11,905 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Alcon Lensx, Inc. against Aalyria Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.